Team Ovary, Memorial Sloan Kettering Cancer Center
@TeamOvary_MSK
Followers
4K
Following
3K
Media
321
Statuses
1K
Official twitter account of Team Ovary, the ovarian cancer service at Memorial Sloan Kettering Cancer Center, views are our own
New York, NY
Joined August 2020
On this #MeetTheTeamMonday, we would like to highlight Dr. Dennis S. Chi, founder of #TeamOvaryMSK, surgeon extraordinaire, and overall unwavering fighter for women with ovarian cancer.
7
5
97
đź©ş How common are diaphragmatic hernias after left diaphragm resections in ovarian cancer surgery? Our Team Ovary team investigated this to inform safer surgical practice. đź”— https://t.co/w5A883ICVi
0
0
2
New from Team Ovary!🧬 Our feasibility study in Obstetrics & Gynecology explores optimal injection techniques for ovarian sentinel lymph node mapping using ICG. Findings support IP ligament injection as a feasible approach for future studies. 📄 https://t.co/ETEec68rfM
pubmed.ncbi.nlm.nih.gov
Injection of ICG into the IP ligament before or after adnexal mass resection led to similar rates of SLN mapping and was deemed feasible by surgeons. Only one SLN was identified contralateral to the...
0
1
6
🎥 We’re proud to share this new video featuring Dr. Moufarrij, who spoke about ovarian cancer awareness and education for Spanish-speaking communities. Thank you to all who helped make this important program possible. 💙 Watch the full video here:
0
0
3
đź©ş Structured pre-op triage matters! Our prospective IJGC study shows RS2.0 improves prediction of resectability in advanced #OvarianCancer. đź”—
0
0
5
Grateful to everyone who joined #Move4Her this Sunday in DC. Hundreds came together to run, walk, and roll for ovarian & gynecologic cancer awareness. Every step brings us closer to hope, healing, and changeđź’ś @GYNCancer
0
1
5
📢 Small cell carcinoma of the ovary, hypercalcemic type: a mini review Proud to share our recent publication in Frontiers in Oncology on this rare and aggressive ovarian cancer. 📖 Read here:
pubmed.ncbi.nlm.nih.gov
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and highly aggressive ovarian neoplasm, predominantly affecting young women, often in their second or third decade of life....
0
1
1
What an empowering night at the NY Liberty game💜. Survivors gathered to share stories, laughter, and tears. We bonded, we lifted, we found strength. Join us Sept 14 at Freedom Plaza DC-or virtually- for #move4her. Race to end women’s cancer @GYNCancer. https://t.co/Up0Y9GdwaO
3
2
14
📢New from Team Ovary in JAMA Surgery! Nearly 1 in 4 women with high-grade serous ovarian cancer had a prior surgery where salpingectomy could have prevented disease — but was missed. 👉Opportunistic salpingectomy + genetic testing are key to prevention. 🔗 https://t.co/e6b8IpCPld
jamanetwork.com
This study attempts to determine the frequency of missed opportunity for salpingectomy with/without oophorectomy among patients diagnosed with high-grade serous carcinoma.
2
7
25
📢 Congrats to our Team Ovary Fellow, Dr. Christina Harlev, on her new study in EJSO @ejsotweets! 👉 HIPEC did not increase cisplatin penetration vs NIPEC in a porcine model, highlighting NIPEC as a potential option for frail patients. 🔗 https://t.co/ry9kMRrVKL
@AarhusUni_int
0
1
8
🎉 Big congrats to Dr. McPherson and Dr. Sohrab Shah’s team on their new Nature paper! Their work on whole-genome doubling in HGSOC offers key insights into disease evolution and treatment. Proud to have them as Team Ovary collaborators! 📖
nature.com
Nature - A single-cell sequencing study using more than 30,000 tumour genomes from human ovarian cancers shows that whole-genome doubling is an ongoing mutational process that drives tumour...
0
12
28
Just published: the RAMP 201 study that led to the first-ever FDA-approved treatment for recurrent low-grade serous ovarian cancer with a KRAS mutation. Avutometinib + defactinib represents a major milestone for this rare and hard-to-treat disease. 📄
0
4
11
And that’s a wrap on possibly my hardest month of fellowship thus far (hours-wise) but also one of my most rewarding! So long Orange Team, hello 4th year of fellowship! #atyourcervix @VanceBroach @TeamOvary_MSK @MSKCancerCenter
1
2
34
Humbled to get this and be a part of such an amazing group of doctors. Can’t make things better alone!! @TeamOvary_MSK @TeamEndo_MSK @MSKCancerCenter
🎉 Congratulations to the IGCS 2025 Award Recipients! We are honored to recognize these outstanding individuals for their impactful contributions to gynecologic oncology through leadership, innovation, mentorship, education, and humanitarian service. 🏆 Lifetime Achievement
11
7
69
Exciting data for the ovarian cancer community! The final results of the ARIEL3 Phase 3 trial evaluating #rucaparib as maintenance treatment in platinum-sensitive, recurrent ovarian carcinoma are now published. Read the full study: https://t.co/DuXP3Ijlo8
#ovarian #Cancer #ARIEL3
0
1
3
Promising combo of Pembro + Olaparib in p53 aberrant/CN-H #endometrialcancer presented by @MariaRubinstein at #ASCO25! We need more biomarkers to find those long term responders. @TeamEndo_MSK @TeamOvary_MSK @MSK_DeptOfMed
1
9
23
So proud of @saramoufarrij1 who is teaching us all about uterine LMS under the guidance of the one and only #marteehensley! @TeamEndo_MSK @TeamOvary_MSK @MSKCancerCenter @MSK_DeptOfMed
2
9
31
Get ready for the results our @PCORI funded trial comparing music therapy with cognitive behavioral therapy for anxiety symptoms in cancer survivors.
Symptom Science & Palliative Care at #ASCO2025 spotlighted innovative psychosocial RCTs: 🎵 Music therapy vs CBT for anxiety 💻 eHealth to ease fear of recurrence 🧠Problem-solving training for young adults A win for scalable, patient-centered care @KevinLiouMD @JunMaoMD
0
4
7
Read more about research from @AliciaLatham10 aimed to investigate the potential of Pap-derived #ctDNA (Pap-ctDNA) as a novel noninvasive tool for EC detection from @ASCO. #ASCO25
🚨 New research presented at #ASCO25 out of @MSKCancerCenter: 🧬 #Papsmear #ctDNA allows for earlier identification of #endometrialcancer 🔗 Read more: https://t.co/Zk0RkvRDyA
#ctDNA #CancerDetection #EarlyDiagnosis #WomensHealth #MedicalInnovation #LiquidBiopsy
1
8
18
Check out @ariadnaroque8 and her awesome #ASCO25 poster building on work from @TeamOvary_MSK looking at #breastcancer after #ovariancancer in this with germline mutations in non-BRCA HR genes, shockingly none! @MSKCancerCenter @MSK_DeptOfMed
1
8
33
Fantastic work currently being presented @ASCO on a very important topic in #endometrialcancer by @WeillCornell resident Dr. Judy Wang. @YingLiu88 @TeamEndo_MSK
So proud of @WeillCornell resident #judywang for her hard work characterizing the germline landscape of early-onset #endometrialcancer! It is unique and needs attention #ASCO25 @TeamEndo_MSK @TeamOvary_MSK @MSK_DeptOfMed @MSKCancerCenter
0
0
11